Chao Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chao Feng has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Guohua Dong
Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, China
2 shared publications- Jiahao Zhou
Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, China
2 shared publications - Jing Wang
Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, China
2 shared publications - Jinhui Shi
Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, China
2 shared publications - Le Ou-Yang
Faculty of Engineering, Shenzhen MSU-BIT University, Shenzhen, China
2 shared publications Runyan Liu
Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, China
2 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (9) , 1039
Publisher Correction: Continual integration of single-cell multimodal data with MIRACLE
- 26 August 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (9) , 1039
Open AccessPublisher Correction: Continual integration of single-cell multimodal data with MIRACLE
- Open Access
- 31 July 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (9) , 988-1004
Continual integration of single-cell multimodal data with MIRACLE
Single-cell sequencing has transformed our understanding of cellular heterogeneity, enabling the construction of multi-omics atlases through data integration. However, conventional atlas updates require full reintegration of all datasets, creating scalability challenges that limit the timeliness and adaptability of biomedical research. Here we present multimodal integration with continual learning (MIRACLE), an online learning framework for scalable multimodal integration. Using dynamic architecture adaptation and data rehearsal, MIRACLE continually integrates diverse datasets while preserving biological fidelity. Across evaluations, MIRACLE achieves accurate online integration with substantially improved efficiency, refining and expanding atlases with new cross-modal, cross-tissue and cross-disease data. Applied to respiratory infections, it reveals both shared and pathogen-specific immune mechanisms in coronavirus disease 2019, influenza A and tuberculosis. Overall, MIRACLE provides an efficient and collaborative solution for the continual integration, sharing and exploration of biological knowledge.
- 31 July 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (9) , 988-1004
Open AccessContinual integration of single-cell multimodal data with MIRACLE
Single-cell sequencing has transformed our understanding of cellular heterogeneity, enabling the construction of multi-omics atlases through data integration. However, conventional atlas updates require full reintegration of all datasets, creating scalability challenges that limit the timeliness and adaptability of biomedical research. Here we present multimodal integration with continual learning (MIRACLE), an online learning framework for scalable multimodal integration. Using dynamic architecture adaptation and data rehearsal, MIRACLE continually integrates diverse datasets while preserving biological fidelity. Across evaluations, MIRACLE achieves accurate online integration with substantially improved efficiency, refining and expanding atlases with new cross-modal, cross-tissue and cross-disease data. Applied to respiratory infections, it reveals both shared and pathogen-specific immune mechanisms in coronavirus disease 2019, influenza A and tuberculosis. Overall, MIRACLE provides an efficient and collaborative solution for the continual integration, sharing and exploration of biological knowledge.
- 7 September 2023
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 30 (12) , 1598-1609
Integrative single-cell transcriptome analysis reveals immune suppressive landscape in the anaplastic thyroid cancer
The tumor immune microenvironment (TIME) in ATC is a complex and diverse ecosystem. It is essential to have a comprehensive understanding to improve cancer treatment and prognosis. However, TIME of ATC and the dynamic changes with PTC has not been revealed at the single-cell level. Here, we performed an integrative single-cell analysis of PTC and ATC primary tumor samples. We found that immunosuppressive cells and molecules dominated the TIME in ATC. Specifically, the level of infiltration of exhausted CD8+ T cells, and M2 macrophages was increased, and that of NK cells, B cells, and M1 macrophages was decreased. The cytotoxicity of CD8+ T cells, γδT cells, and NK cells was decreased, and immune checkpoint molecules, such as LAG3, PD1, HAVCR2, and TIGIT were highly expressed in ATC. Our findings contribute to the comprehension of TIME in both PTC and ATC, offering insights into the immunosuppressive factors specifically associated with ATC. Targeting these immunosuppressive factors may activate the anti-tumor immune response in ATC.
- 7 September 2023
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 30 (12) , 1598-1609
Integrative single-cell transcriptome analysis reveals immune suppressive landscape in the anaplastic thyroid cancer
The tumor immune microenvironment (TIME) in ATC is a complex and diverse ecosystem. It is essential to have a comprehensive understanding to improve cancer treatment and prognosis. However, TIME of ATC and the dynamic changes with PTC has not been revealed at the single-cell level. Here, we performed an integrative single-cell analysis of PTC and ATC primary tumor samples. We found that immunosuppressive cells and molecules dominated the TIME in ATC. Specifically, the level of infiltration of exhausted CD8+ T cells, and M2 macrophages was increased, and that of NK cells, B cells, and M1 macrophages was decreased. The cytotoxicity of CD8+ T cells, γδT cells, and NK cells was decreased, and immune checkpoint molecules, such as LAG3, PD1, HAVCR2, and TIGIT were highly expressed in ATC. Our findings contribute to the comprehension of TIME in both PTC and ATC, offering insights into the immunosuppressive factors specifically associated with ATC. Targeting these immunosuppressive factors may activate the anti-tumor immune response in ATC.